Endo Pharmaceuticals Archives - CDR

Camber launches generic Opana

May 4, 2018 by Chain Drug Review Camber Pharmaceuticals, Endo Pharmaceuticals, Opana, oxymorphone tablets Pharmacy, Supplier News

PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of oxymorphone tablets to our growing portfolio of products. Oxymorphone tablets are the generic version of Opana from Endo Pharmaceuticals and is used to treat moderate to severe pain. Oxymorphone tablets are available in 5 and10 mg – 100 count bottles. Camber said its commitment

Endo cleared to market Belbuca dissolving film painkiller

October 27, 2015 by Chain Drug Review Belbuca, BioDelivery Sciences International, Endo Pharmaceuticals, Rajiv De Silva Pharmacy, Supplier News

DUBLIN, Ireland, and RALEIGH, N.C. — Endo Pharmaceuticals Inc. and BioDelivery Sciences International Inc. have gained approval from the Food and Drug Administration for Belbuca buccal film (buprenorphine), an opioid treatment for chronic pain. The companies said Belbuca is the first and only buprenorphine developed with a dissolving film that is absorbed through the inner